Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has actually axed its once-monthly twin GLP-1/ GIP receptor agonist, finishing (PDF) p...

Daiichi pays Merck $170M to create lung cancer cells T-cell engager pact

.Merck &amp Co. has rapidly gotten back a number of the prices of its Javelin Rehabs purchase, drawi...

BioMarin standstills preclinical genetics treatment for heart disease

.After BioMarin administered a spring clean of its own pipeline in April, the business has actually ...

Eisai plants molecular adhesive SEED along with $1.5 B biobucks deal

.Big Pharmas continue to be caught to the concept of molecular adhesive degraders. The most recent b...

Life scientific research credit score firm introduces along with $600M

.A brand new global life science credit history company, called Symbiotic Resources, has raised more...

BMS ditches TIGIT, bowing out $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing another large wager coming from the Caforio time, canceling ...

Nuvation stops wager inhibitor after looking at phase 1 record

.After having a look at stage 1 information, Nuvation Bio has actually decided to halt deal with its...

' Medical instinct' led FDA specialists to back Zevra's unusual illness med

.Zevra Therapies' uncommon disease medicine appears to become on the road to approval this autumn af...

Pfizer takes $230M reached after axing failed DMD gene treatment

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) genetics therapy failure has actually gone a $230...

AC Immune finds 'landmark' prospective in Alzheimer's medication records

.After much more than two decades of work on neurodegenerative conditions, Swiss biotech a/c Immune ...